ArticleJournal of neuroinflammation2018

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.

Concepción García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.